Professor David M Reid was awarded the iWantGreatCare certificate of excellence in 2024 for delivering outstanding care.
Reviews
I saw Professor Reid at his private clinic in Aberdeen to discuss a diagnosis of severe osteoporosis. I found him to be very knowledgable and helpful. He has been very thorough in reviewing my diagnosis and seeking the best treatment option for me. I highly recommend him.
Professor Reid is courteous and caring in his approach. I have full confidence in him and would be happy to recommend him. EC
Professor Reid has been monitoring my osteoporosis and advising on when to pause and restart treatment. As other reviewers have said, he is unhurried in his approach, takes the time to explain matters clearly and listens well. Whilst my own situation may be relatively simple compared to that others face, I would happily recommend him
Saw Professor Reid for a consultation on New Year's Eve. He spent plenty of time listening carefully to my concerns and examined me thoroughly.
Highly recommended.
I met with Professor Reid on the 7th of December 2018 in Aberdeen to obtain advice on taking Alendronic Acid for Osteoporosis and the effect it has on my dental implants.
Professor Reid was very pleasant and took time in explaining in detail and took away all the fears I had. He is a kind and caring doctor and I thank him for his advice.
Specialises in
- Rheumatology
Profile
Professor David Reid is Emeritus Professor of Rheumatology at the University of Aberdeen and was previous Head of the School of Medicine & Dentistry at the University.
He is a consultant rheumatologist and has been involved in providing specialist osteoporosis services with a particular emphasis on bone densitometry for 30 years. He therefore has a special interest in the use and interpretation of DXA or DEXA the main measurement tool.
He has over 300 original papers and reviews, largely on his research interests which include the utility of bone mass assessment, assessment of risk of fracture, secondary osteoporosis, glucocorticoid osteoporosis and the assessment of long-term disease activity and drug adverse effects in rheumatic diseases.
He was Chair of the Board of Trustees of the UK National Osteoporosis Society from 2008-2012 and has previously chaired their Research Grants Committee and Medical Board. Until late 2013 he was the Chair of the Arthritis Research UK Clinical Studies Group with responsibility for advising on the needs for clinical trials in bone diseases. He has been a member of numerous national committees most recently including the UK Medical Schools Council, the UK Health Education Advisory Committee and Scottish Stratified Medicine Innovation Centre Board.
He is now undertaking NHS locums in rheumatology and practicing privately in osteoporosis and acute rheumatology in London and Aberdeen. He is a great advocate for new and evolving therapies for osteoporosis.